Indiana University scientists with expertise in optometry and artificial intelligence are among the first three groups of researchers to receive support from a new program from the National Institutes of Health supporting the emerging field of “oculomics,” which uses the eye as a lens on diseases that affect the whole body.
PharmassêtX gains FDA orphan drug status for IBD treatment
The safety and effectiveness of EGCG for IBD were supported by peer-reviewed studies. Credit: MMD Creative/Shutterstock. PharmassêtX has received US Food and Drug Administration’s (FDA)
July 11, 2024